Sequential causal inference: application to randomized trials of adaptive treatment strategies
- PMID: 17914714
- PMCID: PMC2723128
- DOI: 10.1002/sim.3039
Sequential causal inference: application to randomized trials of adaptive treatment strategies
Abstract
Clinical trials that randomize subjects to decision algorithms, which adapt treatments over time according to individual response, have gained considerable interest as investigators seek designs that directly inform clinical decision making. We consider designs in which subjects are randomized sequentially at decision points, among adaptive treatment options under evaluation. We present a sequential method to estimate the comparative effects of the randomized adaptive treatments, which are formalized as adaptive treatment strategies. Our causal estimators are derived using Bayesian predictive inference. We use analytical and empirical calculations to compare the predictive estimators to (i) the 'standard' approach that allocates the sequentially obtained data to separate strategy-specific groups as would arise from randomizing subjects at baseline; (ii) the semi-parametric approach of marginal mean models that, under appropriate experimental conditions, provides the same sequential estimator of causal differences as the proposed approach. Simulation studies demonstrate that sequential causal inference offers substantial efficiency gains over the standard approach to comparing treatments, because the predictive estimators can take advantage of the monotone structure of shared data among adaptive strategies. We further demonstrate that the semi-parametric asymptotic variances, which are marginal 'one-step' estimators, may exhibit significant bias, in contrast to the predictive variances. We show that the conditions under which the sequential method is attractive relative to the other two approaches are those most likely to occur in real studies.
Similar articles
-
Sample size calculations for evaluating treatment policies in multi-stage designs.Clin Trials. 2010 Dec;7(6):643-52. doi: 10.1177/1740774510376418. Epub 2010 Jul 14. Clin Trials. 2010. PMID: 20630903 Free PMC article.
-
Targeted maximum likelihood based causal inference: Part I.Int J Biostat. 2010;6(2):Article 2. doi: 10.2202/1557-4679.1211. Int J Biostat. 2010. PMID: 21969992 Free PMC article.
-
Doubly robust inference for targeted minimum loss-based estimation in randomized trials with missing outcome data.Stat Med. 2017 Oct 30;36(24):3807-3819. doi: 10.1002/sim.7389. Epub 2017 Jul 25. Stat Med. 2017. PMID: 28744883
-
Causal evidence in health decision making: methodological approaches of causal inference and health decision science.Ger Med Sci. 2022 Dec 21;20:Doc12. doi: 10.3205/000314. eCollection 2022. Ger Med Sci. 2022. PMID: 36742460 Free PMC article. Review.
-
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217. Cochrane Database Syst Rev. 2022. PMID: 36321557 Free PMC article.
Cited by
-
Design and inference for the intent-to-treat principle using adaptive treatment.Stat Med. 2015 Apr 30;34(9):1441-53. doi: 10.1002/sim.6421. Epub 2015 Jan 11. Stat Med. 2015. PMID: 25581413 Free PMC article.
-
HETEROGENEITY IN TREATMENT EFFECT AND COMPARATIVE EFFECTIVENESS RESEARCH.China Health Rev. 2011 Oct;2(3):2-7. China Health Rev. 2011. PMID: 25364768 Free PMC article.
-
Adaptive treatment strategies in chronic disease.Annu Rev Med. 2008;59:443-53. doi: 10.1146/annurev.med.59.062606.122232. Annu Rev Med. 2008. PMID: 17914924 Free PMC article. Review.
-
Sample size calculations for evaluating treatment policies in multi-stage designs.Clin Trials. 2010 Dec;7(6):643-52. doi: 10.1177/1740774510376418. Epub 2010 Jul 14. Clin Trials. 2010. PMID: 20630903 Free PMC article.
-
What have we learned about trial design from NIMH-funded pragmatic trials?Neuropsychopharmacology. 2010 Dec;35(13):2491-501. doi: 10.1038/npp.2010.115. Epub 2010 Aug 25. Neuropsychopharmacology. 2010. PMID: 20736990 Free PMC article.
References
-
- Lavori PW, Dawson R. Dynamic treatment regimes: practical design considerations. Clinical Trials. 2004;1:9–20. - PubMed
-
- Murphy S. An experimental design for the development of adaptive treatment strategies. Statistics in Medicine. 2005;24:1455–1481. - PubMed
-
- Thall PF, Millikan RE, Sung HG. Evaluating multiple treatment courses in clinical trials. Statistics in Medicine. 2000;19:1011–1028. - PubMed
-
- Schneider LS, Tariot PN, Lyketsos CG, Dagerman KS, Davis KL, Davis S, Hsiao JK, Jeste DV, Katz IR, Olin JT, Pollock BG, Rabins PV, Rosenheck RA, Small GW, Lebowitz B, Lieberman JA. National Institute of Mental Health Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE): Alzheimer disease trial methodology. American Journal of Geriatric Psychiatry. 2001;9:346–360. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources